A recent survey showed that 86% of Americans feel their healthcare provider should discuss clinical trial opportunities with patients diagnosed with a disease as part of their standard of care for that patient and/or disease (https://www.eurekalert.org/pub_releases/2017-07/r-asd072517.php). While this may be obvious to us, another 90% believe that clinical trials are important to advancing science. While I was delighted to hear these findings, I also believe that they present a real opportunity for eyecare practices that are either involved, or would like to be involved, in promoting vision science to continue to find ways to improve ocular health.
Jason J. Nichols, OD, MPH, PhD
J&J Vision Announces Agreement to Acquire TearScience
Johnson & Johnson Vision (J&J Vision) announced a definitive agreement to acquire TearScience, Inc., a medical device manufacturer dedicated to evaluating meibomian gland health and treating meibomian gland dysfunction (MGD). According to J&J Vision, the acquisition of TearScience will provide strategic value, further expanding its leading portfolio of products in eye health. TearScience received FDA clearance for an office-based approach to image meibomian glands and treat MGD and has sales in the United States and major markets globally.
J&J Vision will acquire TearScience through its surgical vision operating company, Abbott Medical Optics Inc.; financial terms of the transaction have not been disclosed. The transaction is expected to close by the end of the year. The closing is subject to antitrust clearance and other customary closing conditions. Following the expected closing, sales will be reported in the Medical Devices segment, under Vision Care.
World Sight Day Challenge 2017
Optometry Giving Sight is once again inviting all those who value good vision to support its major fundraising campaign for the year, the World Sight Day Challenge. The Challenge will run throughout October, with World Sight Day being celebrated on Oct. 12. This year’s initiative kicked off on Aug. 1.
As part of its support for Our Children’s Vision, Optometry Giving Sight will fund projects that give sight and hope to more than 1 million children in 2017. For the past 10 years, thousands of optometrists, their staff, patients, students, and colleagues in industry have taken the World Sight Day Challenge by making a tax-deductible donation and/or by raising funds in their practice, school, or company.
To donate or to pledge your participation by selecting one of the Bronze, Silver, Gold, or Platinum Award levels, visit www.givingsight.org or call (303) 526-0430.
BCLA Offers Myopia “Roadshow”
Kate Gifford, BAppSc(Optom)Hons, GCOT, will hold events in Birmingham, Manchester, and London as part of a series of roadshows organized by the British Contact Lens Association (BCLA).
The series of evening meetings, titled “Fitting Kids – The Facts and Future of Myopia Control,” will give eyecare practitioners the opportunity to gain first-hand knowledge of how to run a successful children’s contact lens clinic.
Topics discussed will include contact lens myopia control (e.g., lens designs and outcomes), the myopia control imperative, unanswered questions, clinical cases, and a future picture of myopia control.
Meanwhile, Paul Gifford, PhD, will present a lecture titled “The Science and innovation of Myopia Control.” The presentation will cover the currently available methods for controlling progression of myopia, the evidence supporting their use in practice, and understanding the clinical imperative to do so.
The first evening meeting will be held at the Manchester Museum on Sep. 26. Subsequent meetings will be held in Birmingham at the Think Tank Museum on Sep. 27 and at the Holiday Inn Hotel in Wembley, London on Sep. 29. All meetings will take place from 6:00 p.m. to 9:00 p.m. The meetings are free to BCLA members; cost for non-members will be £25.
Direct-to-Consumer Contact Lens Startup Opens for Business in the United Kingdom
Waldo, a direct-to-consumer provider of daily disposable contact lenses in the United Kingdom, began shipping product on Aug. 1. The company was founded by Harvard University graduate Ashleigh Hinde.
To start, customers can submit their prescription and sign up for a free one-month trial (30 daily disposable lenses for each eye); the only cost will be £2.95 for shipping. Then, for £24 a month for 60 lenses, Waldo will send lenses every 30 days as needed. Customers have the ability to cancel their subscription anytime by logging into their profile.
Waldo’s contact lenses block at least 95% UVB and 70% UVA radiation. The daily disposable lenses are available in powers from –12.00D to +4.00D in an 8.5mm base curve.
Waldo has partnered with an internationally recognized and certified supplier that employs a fully automated manufacturing process in a class 100 sterile environment. According to Waldo, the manufacturer uses an Automatic Optical Inspection (AOI) system to make sure that the lenses are perfect, which eliminates human bias and error in the inspection of the lenses. Waldo contact lenses have received a CE certification mark, and the company follows the ISO 13485 manufacturing standard.
Waldo has an in-house optometrist who is available online to answer questions, but the company also has a customer services team who can find customers a local eyecare practitioner and book appointments for them. Currently, Waldo lenses are only available online. Waldo is currently developing an app and plans to open pop-up stores where customers will be able to see an eyecare practitioner face-to-face and buy lenses. The company will initially operate only in the United Kingdom, but has plans to expand internationally.
BHVI Offers Online Myopia Course
On Aug. 14, the Brien Holden Vision Institute (BHVI) will be offering an online course titled “Managing Myopia.” The course takes the latest advances in research and makes them clinically relevant for all eyecare practitioners, according to BHVI. At the end of the course, participants should be able to successfully implement an appropriate myopia management plan to limit myopia progression in their patients.
BHVI says that this course is an engaging learning experience, allowing participants to apply and relate their learning to their daily practice. The course includes 14 instructional videos and eight interactive case studies (both of which can be completed at the participants’ own pace). In addition, there will be an interactive webinar held on Aug. 31.
All content is delivered online and can be accessed using a desktop PC, tablet, or mobile device. The course will take around five hours in total, including attending the webinar. It is also COPE Qualified for five points.
Bio-Tissue to Expand Market Presence in the United Kingdom and Ireland
Bio-Tissue, Inc., a business unit of TissueTech, Inc., announced a strategic agreement with Scope, an eyecare company offering ophthalmic products in the United Kingdom and Ireland. The companies will work together to bring Bio-Tissue’s Prokera biologic corneal bandage devices to the United Kingdom and Irish eyecare professionals market.
2nd Annual International Forum for Scleral Lens Research
The 2nd annual International Forum for Scleral Lens Research (IFSLR) symposium will be held in Houston on Dec. 4, 2017. The primary focus of the meeting will be scleral contact lenses; it represents the only meeting of its kind to deal with scleral lens research and its application to clinical practice.
IFSLR is a group of researchers, clinicians, and industry partners interested in advancing and improving scleral contact lenses. The one-day symposium will present a unique and interactive format—approximately half of the available time is dedicated to an open discussion in which all attendees may participate. The meeting focuses on specific issues in which the presenters clarify what evidence is available or needed.
Each focus area (such as vision from improved optics, hypoxia, solutions, etc.) starts with an initial address by a keynote speaker, followed by up to four presenters providing expert statements; all speakers are acknowledged experts with a publishing and/or clinical record. In addition, a number of distinguished scleral lens practitioners are invited to serve as a VIP (Very Important Panelist); they will participate in the ensuing discussion and can assist in answering questions raised by attendees.
ABB Optical Group Names New Senior Vice President of Operations
ABB Optical Group announced that Steve Heft has joined the company as senior vice president of operations. In his new position, he will provide strategic and tactical direction for ABB Optical Group’s distribution centers. He will streamline operations for enhanced profitability, productivity, and efficiency. Focused on a customer-centric approach, ABB Optical says that Mr. Heft will align all aspects of operations to deliver a best-in-class customer experience.
Mr. Heft has more than 20 years of experience in supply chain and operational leadership. Prior to joining ABB Optical Group, he directed procurement, distribution, manufacturing, engineering, quality, and design organizations in Europe, Latin America, and North America. He will be based in the company’s office in Coral Springs, FL.
Call for Papers & Posters – 1 Month Until Deadline
Authors are invited to submit abstracts for the Free Paper Section and the Scientific Poster Competition of the Global Specialty Lens Symposium. Abstracts related to to presbyopia, keratoconus, corneal topography, post penetrating keratoplasty or related irregular corneal surface, myopia control, orthokeratology, and lens care topics are welcome.
The GSLS will be held January 25-28, 2018 at The newly renovated Tropicana Hotel in Las Vegas. Visit www.GSLSymposium.com for more information. Web submissions only. Deadline for submissions is August 31, 2017.
Approximately how frequently do you use a bandage contact lens?
Post-radial keratotomy (RK) corneas can mimic pellucid marginal degeneration (PMD) with their severe drop-off inferiorly. Larger scleral lenses (> 16.0mm) generally work well in these situations, especially when toric haptics are utilized.
We thank Dr. Arnold for this image and welcome photo submissions from our other readers! It is easy to submit a photo for consideration for publishing in Contact Lenses Today. Simply visit http://www.cltoday.com/upload/upload.aspx to upload your image. Please include a detailed explanation of the photo and your full name, degree or title, and city/state/country.
CARE SOLUTION CORNER
Andrew D. Pucker, OD, PhD
A Case of Lost and Found
Morjaria et al recently presented a case report in BMJ1 (which was further covered by The New York Times) that described how a 67-year-old woman unknowingly reported for cataract surgery with 27 monthly soft contact lenses trapped in her superior fornix.1 The patient did report that she had a mild foreign body sensation, though she was not worried about it.2
Over the years, I have encountered a number of patients who have worried about losing a contact lens behind their eye. In fact, I would say that this concern is among the top reasons why I have received emergency phone calls from patients. Thankfully, there are a number of anatomical structures that prevent contact lenses from getting lost behind the eye,3 though the eye can still retain contact lenses in other locations.1
In my experience, dislocated contact lenses generally make their way back to the externally visible ocular surface with repeated blinking, but this case report highlights that dislocated lenses may not always surface. The likelihood of having contact lenses retained by the eye may be increased deep-set eyes or decreased vision, much like in the above case.1
Therefore, we should educate our patients to always keep track of their contact lenses. We should also educate them that if they lose a contact lens and suspect that it is still on their eye, they should seek out an eyecare provider for additional evaluation. Clinicians should also routinely flip the eyelids of contact lens wearers to rule out dislocated contact lenses as well as to rule out contact lens-related pathologies, such as giant papillary conjunctivitis, so that situations like one explained above can be avoided.1,4
1. Morjaria R, Crombie R, Patel A. Retained contact lenses. BMJ. 2017 Jul 5;358:j2783.
2. Chokshi N. 27 Contact Lenses Are Found in Woman’s Eye, Doctors Report. The New York Times. 2017 July 17. Available at https://www.nytimes.com/2017/07/17/health/contact-lenses-stuck-eye.html. Accessed on Aug. 1, 2017.
3. Remington LA. Clinical anatomy of the Visual System, 2nd ed. Butterworth-Heinemann, Boston. 2005:vii, p. 292.
4. Allansmith MR, Korb DR, Greiner JV, Henriquez AS, Simon MA, Finnemore VM. Giant papillary conjunctivitis in contact lens wearers. Am J Ophthalmol. 1977 May;83:697-708.
MATERIALS & DESIGNS
David L. Kading, OD
When Easy Is Ignored
I think that I am pretty open minded and am willing to try most anything new. But when I think about new ideas, I naturally form opinions and ideas based on my belief patterns from the past. One such belief that I have is that orthokeratology is a complex and difficult thing. And, although I see orthokeratology patients on a daily basis, I generally find it to be a rewarding “challenge.”
Recently, I had the opportunity to spend time with an orthokeratology manufacturer that we have here in the states. The manufacturer shared an independent study with me that revealed 86% first-fit success with empirical fitting of the company’s lens; with the second lens, the fit success was 99%. (Note: I am purposely not including the study reference with this column because I am not trying to sell anyone’s lenses.) With nearly 90% first-fit success using empirical fitting, this lens is more successful than most of my multifocal fits.
I am not implying that we should be cavalier and just fit any patient without reservation. Instead, proper prescription and patient selection should still be part of the process. However, once I learned this, I questioned why more of us are not fitting orthokeratology. If you’re not fitting orthokeratology lenses, please look up an orthokeratology lab, call them, and start working to learn the process soon. It may be easier than you ever thought.
Corneo-Scleral Contact Lenses in an Uncommon Case of Keratoconus with High Hyperopia and Astigmatism
The purpose of this study was to analyze the visual quality achieved by fitting corneo-scleral contact lenses (CSCLs) in an uncommon case of bilateral keratoconus, high hyperopia, and astigmatism.
A 45-year-old man presented for an eye examination due to the unsatisfactory quality of his vision with soft toric contact lenses. He presented with high hyperopia and astigmatism with bilateral keratoconus. He was fitted with CSCLs to correct his irregular astigmatism and ocular aberrations. A diagnostic trial set was used in the fitting process, and he was assessed according to standardized fitting methodology. Visual acuity, corneal topography, biometry, and ocular aberrations were evaluated. The follow-up period was one year.
The best-spectacle-corrected visual acuity was 20/32 with +8.00 / –4.50 × 30° OD and 20/25 with +7.75 / –2.25 × 120° OS. After CSCL fitting, visual acuity was improved to 20/20 and 20/16 OD and OS, respectively. The patient wore these contact lenses for an average of 13 hours per day. The total high-order aberrations decreased by approximately 79% OD (2.37μm to 0.50μm) and 47% OS (1.04μm to 0.55μm) after CSCL fitting. Visual quality and wearing time were maintained after one year of wearing CSCLs. In addition, no adverse ocular effects were found during this period.
This case report describes how the patient was successfully fitted with CSCLs for management of keratoconus with high hyperopia and astigmatism. The lenses provided optimal visual quality along with prolonged wear times and no adverse effects to the cornea.
Porcar E, Montalt JC, España-Gregori E, Peris-Martínez C. Corneo-scleral contact lenses in an uncommon case of keratoconus with high hyperopia and astigmatism. Cont Lens Anterior Eye. 2017 Jul 13. [Epub ahead of print]